Acadia Healthcare Company, Inc.

Health Care
Medical Specialities
www.acadiahealthcare.com

Earnings Score
Moat Score
Safety Score

Market Cap $3.73B
PE 13
Debt $1.95B
Cash $82.15M
EV $5.59B
FCF -$496.32M

Earnings

loading chart...

Sales & Net Margins

loading chart...

Earnings	$280.73M
EBIT	$383.84M
ROE	9%
ROA	7%
FCF	-$496.32M
Equity	$3.03B
Growth Stability	-2K%
PE	13.27
PEG	1.53
PB	1.23
P/FCF	-7.51
P/S	1.19
Price/Cash	0.02
Debt/Equity	0.64
Debt/FCF	-3.93
Net Margins	9%
Op. Margins	12%
Earnings CAGR	6%
Sales Growth YoY	9%
Sales Growth QoQ	2%
Sales CAGR	0%
FCF CAGR	4%
Equity CAGR	6%
Earnings Stability	0.07
Earnings Growth YoY	-131%
Earnings Growth QoQ	-13%

Earnings CAGR 5Y	9%
Sales CAGR 5Y	4%
FCF CAGR 5Y	-12%
Equity CAGR 5Y	6%
Earnings CAGR 3Y	12%
Sales CAGR 3Y	12%
FCF CAGR 3Y	-15%
Equity CAGR 3Y	5%
Market Cap	$3.73B
Revenue	$3.12B
Assets	$5.87B
Total Debt	$1.95B
Cash	$82.15M
Shares Outstanding	91.39M
EV	5.59B
Earnings Score	7%
Moat Score	85%
Safety Score	35%
Final Score	42%
Working Capital	42.56M
Current Ratio	1.07
Shares Growth 3y	2%
Equity Growth QoQ	3%
Equity Growth YoY	12%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...

Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities in the United States, United Kingdom, and Puerto Rico. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The U.S. facilities receive the largest proportion of payments from Medicaid, with the second- largest proportion from commercial payors. In the United Kingdom, the majority of Acadia's revenue comes from its healthcare facilities, and virtually all of the payment received is from the National Health Service.

SEC Filings

Direct access to Acadia Healthcare Company, Inc. (ACHC) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

2024
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2023
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2022
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31

Sector Comparison

How does Acadia Healthcare Company, Inc. compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Acadia Healthcare Company, Inc. compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

CAGR 6%

Stability 7%

loading chart...

Acadia Healthcare Company, Inc. Discounted Cash Flow

Fully customizable DCF calculator online for Acadia Healthcare Company, Inc..

Years

Calculation mode

= -$6.7B

	0	1	2	3	4	5	6	7	8	9	10	TV
fcf	-$496M	-$519M	-$542M	-$566M	-$591M	-$618M	-$646M	-$674M	-$705M	-$736M	-$769M	-$7.7B
DCF		-$471M	-$448M	-$425M	-$404M	-$384M	-$364M	-$346M	-$329M	-$312M	-$297M	-$3B
Value	-$6.7B

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years	12/2014	12/2015	12/2016	12/2017	12/2018	12/2019	12/2020	12/2021	12/2022	12/2023	TTM
Net Margins	8%	6%	0%	7%	-6%	4%	-32%	8%	10%	-1%	9%
ROA	-	9%	10%	9%	10%	9%	3%	6%	8%	-0%	7%
ROE	-	7%	0%	8%	-8%	4%	-35%	8%	10%	-1%	9%

Net Margins (9.37%)

Net Margins are at a level that is not too high nor too low. They are not a competitive advantage but they are not a competitive disadvantage either.

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years	12/2014	12/2015	12/2016	12/2017	12/2018	12/2019	12/2020	12/2021	12/2022	12/2023	TTM
Debt over FCF	-	-68.46	52.63	26.16	43.49	66.86	7.48	11.8	16.82	36.94	-3.93
Debt over Equity	1.28	1.38	1.56	1.29	1.4	1.29	1.74	0.61	0.5	0.51	0.64
Growth Stability	-	-	-	100%	-167%	100%	-2K%	-	-	-	-2K%

Good Debt/FCF ratio (-3.93)

Net Margins are high enough to offer a good protection on the profits in case of higher costs or higher interests. Furthermore higher margins reduce earnings’ volatility.

Good Debt/Equity ratio (0.64)

The company is not overleveraged and has a good balance between equity and debt.

Bad Graham’s Stability (-2K%)

The company has a bad stability in its earnings, which is a sign of a bad competitive advantage.

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years	12/2014	12/2015	12/2016	12/2017	12/2018	12/2019	12/2020	12/2021	12/2022	12/2023	CAGR 5Y
Revenue YoY growth	-	77%	56%	1%	5%	3%	-33%	11%	13%	12%	4%
Earnings YoY growth	-	34%	-96%	5K%	-188%	-162%	-717%	-128%	43%	-108%	9%
Equity YoY growth	-	91%	29%	19%	-9%	7%	-24%	33%	12%	-1%	6%
FCF YoY growth	-	-2K%	-290%	98%	-41%	-36%	817%	-71%	-35%	-55%	-12%